Evidence map›Paper›PMID 22222846›Full record

ArticleMicrobes and infection2012

Infant rat infection modifies phenotypic properties of an invasive nontypeable Haemophilus influenzae.

David Tsao, Kevin L Nelson, Daniel Kim, Arnold L Smith

Abstract read
In one paragraph

Article in Microbes and infection, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David TsaoRinat Laboratories, Biotherapeutics Division, Pfizer, San Francisco, CA 94080, USA.
Kevin L Nelson
Daniel Kim
Arnold L Smith
Seattle Children's Hospital · US

Funding

Role of phase-variable DNA methylase in virulence of Haemophilus influenzaeR21AI072459 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI SMITH, ARNOLD LEE · 2007 to 2008
$512k
NIAID NIH HHS R21 AI072459
6 · The paper itself

Abstract

Enhancing the virulence trait of a specific bacterium in an animal model is often performed prior to the use of the strain for ex vivo human studies, such as reactivity with complement and antibody, or with phagocytic cells. For example, in Streptococcus pneumoniae mouse passage is used to enhance capsule production. While investigating an unusual serum-resistant unencapsulated Haemophilus influenzae (R2866), we found that animal passage yielded an isolate (R3392) which had decreased resistance to human serum, but increased virulence in Chang conjunctival cell monolayers, but with less invasion and transcytosis of polar H292 cells. We examined 90 colonies recovered from three infant rats for phase variants of LPS biosynthetic genes. In 88 colonies lgtC was OFF due to tetrameric repeat mediated slipped-strand mispairing at the time of DNA replication, while there was no variation in lic1A, lic2A, lic3A, lexA and oaf A. With lgtC OFF the LPS lacks Galα1-4βGal, an epitope mimicking the human p(k) blood group, and molecular mimicry is lost. Selection for strain susceptible to NHS in the infant rat was not antibody mediated. We conclude that the passage of pathogens virulent in humans and animals may select for phenotypes only relevant for the animal species used.

Indexed as

Blood Bactericidal ActivitySerial PassageAdultAnimalsAnimals, NewbornBacterial ProteinsCell LineConjunctivaFemaleHaemophilus InfectionsHaemophilus influenzaeHumansInhibitory Concentration 50LipopolysaccharidesMicrobial ViabilityPhenotypeBacterial ProteinsLipopolysaccharides

Identifiers

PMID22222846
PMCPMC3348267
OpenAlexW2085030710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.